Paper · 42479094
Macrophage-derived FGF21 Restrains Endometritis By Suppressing Inflammation and Promoting Repair Through FGFR1.
Liu H and 6 others. Inflammation, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Macrophage-derived FGF21 Restrains Endometritis By Suppressing Inflammation and Promoting Repair Through FGFR1. Papers, record 42479094. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42479094
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Macrophage-derived FGF21 Restrains Endometritis By Suppressing Inflammation and Promoting Repair Through FGFR1.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblast Growth Factors | Major topic |
| Receptor, Fibroblast Growth Factor, Type 1 | Major topic |
| Endometritis | Major topic |
| Macrophages | Major topic |
| Inflammation | Major topic |
| Female | |
| Animals | |
| Mice | |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82572289 | National Natural Science Foundation of China | PubMed | ||
| LBY24H040012 | Zhejiang Provincial Natural Science Foundation of China | PubMed | ||
| 437502607 | Provincial Peak Discipline (Pharmaceutical Sciences) of Wenzhou Medical University | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,170,255 | Melatonin inhibits endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in lipopolysaccharide-induced endometritis in mice. | Int Immunopharmacol | 2018 | https://conductscience.org/library/papers/30170255 | PubMed |
| 2 | 39,955,281 | FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice. | Nat Commun | 2025 | https://conductscience.org/library/papers/39955281 | PubMed |
| 3 | 29,135,053 | Chronic endometritis in patients with unexplained infertility: Prevalence and effects of antibiotic treatment on spontaneous conception. | Am J Reprod Immunol | 2018 | https://conductscience.org/library/papers/29135053 | PubMed |
| 4 | 38,169,293 | Luteolin attenuates Staphylococcus aureus-induced endometritis through inhibiting ferroptosis and inflammation via activating the Nrf2/GPX4 signaling pathway. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38169293 | PubMed |
| 5 | 42,062,807 | Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF-κB-mediated inflammation and alleviate atherosclerosis. | Br J Pharmacol | 2026 | https://conductscience.org/library/papers/42062807 | PubMed |
| 6 | 40,527,315 | FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression. | Cell Metab | 2025 | https://conductscience.org/library/papers/40527315 | PubMed |
| 7 | 40,383,912 | CD44 is a macrophage receptor for TcdB from Clostridioides difficile that via its lysine-158 succinylation contributes to inflammation. | Gut Microbes | 2025 | https://conductscience.org/library/papers/40383912 | PubMed |
| 8 | 40,367,940 | FGF21 reverses MASH through coordinated actions on the CNS and liver. | Cell Metab | 2025 | https://conductscience.org/library/papers/40367940 | PubMed |
| 9 | 41,684,313 | Endometrial microbiota-targeted therapies for chronic endometritis-associated recurrent implantation failure and their impact on IVF outcomes: A systematic review and methodological quality assessment. | Acta Obstet Gynecol Scand | 2026 | https://conductscience.org/library/papers/41684313 | PubMed |
| 10 | 40,571,050 | B1344 ameliorates non-alcoholic steatohepatitis in HFCD-HF/G-induced mice: exploring the therapeutic efficacy and mechanism of a novel FGF21 analogue. | Eur J Pharmacol | 2025 | https://conductscience.org/library/papers/40571050 | PubMed |
1 to 10 of 37
See all 37 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGF21 | 26,291 | PubTator's text mining | https://conductscience.org/library/genes/26291 | NCBI Gene |
| FGFR1 | 2,260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42479094
GET https://conductscience.org/api/papers/v1/42479094/references?page=2